| pubmed-article:21687392 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21687392 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:21687392 | lifeskim:mentions | umls-concept:C0225336 | lld:lifeskim |
| pubmed-article:21687392 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
| pubmed-article:21687392 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:21687392 | lifeskim:mentions | umls-concept:C0935989 | lld:lifeskim |
| pubmed-article:21687392 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:21687392 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21687392 | pubmed:dateCreated | 2011-6-20 | lld:pubmed |
| pubmed-article:21687392 | pubmed:abstractText | We sought to maximize the antitumor effect of an anticancer vaccine based on genetically modified endothelial cells by combining it with the platelet-derived growth factor receptor inhibitor imatinib. | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21687392 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21687392 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:21687392 | pubmed:month | May | lld:pubmed |
| pubmed-article:21687392 | pubmed:issn | 2005-6745 | lld:pubmed |
| pubmed-article:21687392 | pubmed:author | pubmed-author:KuJa HyeonJH | lld:pubmed |
| pubmed-article:21687392 | pubmed:author | pubmed-author:KwakCheolC | lld:pubmed |
| pubmed-article:21687392 | pubmed:author | pubmed-author:KimHyeon... | lld:pubmed |
| pubmed-article:21687392 | pubmed:author | pubmed-author:ParkYong... | lld:pubmed |
| pubmed-article:21687392 | pubmed:author | pubmed-author:LeeEunhyeE | lld:pubmed |
| pubmed-article:21687392 | pubmed:author | pubmed-author:HaSeung... | lld:pubmed |
| pubmed-article:21687392 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21687392 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:21687392 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21687392 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21687392 | pubmed:pagination | 327-34 | lld:pubmed |
| pubmed-article:21687392 | pubmed:dateRevised | 2011-8-1 | lld:pubmed |
| pubmed-article:21687392 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21687392 | pubmed:articleTitle | Combined treatment with anticancer vaccine using genetically modified endothelial cells and imatinib in bladder cancer. | lld:pubmed |
| pubmed-article:21687392 | pubmed:affiliation | Department of Urology, Seoul National University College of Medicine, Seoul, Korea. | lld:pubmed |
| pubmed-article:21687392 | pubmed:publicationType | Journal Article | lld:pubmed |
